A molecular graded prognostic assessment (molGPA) model specific for estimating survival in lung cancer patients with leptomeningeal metastases

Authors:

Abstract
No abstract available
Funding Information
  • National Key R&D Program of China (2016YFC1303800)
  • National Health and Family Control Committee (201402031)
  • Guangdong Provincial Applied Science and Technology Research & Development Program (2016B020237006)
  • Public Utility and Capacity Establishment Program of Guangdong Science and Technology Department (2014A020212225)
  • National Natural Science Foundation of China (81572289)
  • Project of National Natural Science Foundation (81802298)

This publication has 31 references indexed in Scilit: